Clinical trial
Albumin in Acute Ischemic Stroke Trial
NCT00235495 · University of Miami, Other · Terminated
Key facts
| NCT number | NCT00235495 |
|---|---|
| Title | Albumin in Acute Ischemic Stroke Trial |
| Official title | A Phase III Randomized Multicenter Clinical Trial Of High-Dose Human Albumin Therapy For Neuroprotection In Acute Ischemic Stroke |
| Acronym | ALIAS |
| Lead sponsor | University of Miami, Other |
| Collaborators | National Institute of Neurological Disorders and Stroke (NINDS) NIH University of Calgary Medical University of South Carolina Neurological Emergencies Treatment Trials Network (NETT) |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Ischemic Stroke |
| Intervention type | Biological, Drug |
| Interventions | Albumin, Saline |
| Enrollment | 841 |
| Start date | Jun 1, 2006 |
| Primary completion | Feb 1, 2013 |
| Completion | Feb 1, 2013 |
| First posted | Oct 10, 2005 |
| Last update posted | Dec 17, 2019 |
| Countries | Canada, Finland, Israel, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: